Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Albumin in Pancreaticoduodenectomy
NCT04418739Phase 2Unknown
- Sponsor
- Hospital Canselor Tuanku Muhriz
- Start
- Jan 2020
- Primary completion
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of albumin (human) in pancreatic cancer (PC), periampullary cancer, sponsored by Hospital Canselor Tuanku Muhriz. Status: unknown.
02
Drugs
albumin (human)
03
Conditions
pancreatic cancer (PC)periampullary cancer
Beyond the preview
Go deeper on NCT04418739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04418739.